Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2009-02-04

FDA Approved: OXYBUTYNIN CHLORIDE — Original Application (Chartwell RX, LLC)

View source ↗

Summary

The FDA approved Chartwell RX, LLC's original application for oxybutynin chloride, enabling a generic option for treating overactive bladder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oxybutynin chloride (Oxybutynin chloride)

Snippet

ORIG AP for OXYBUTYNIN CHLORIDE (OXYBUTYNIN CHLORIDE)